N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44% Market Closed
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

NewGLab Pharma Co Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NewGLab Pharma Co Ltd
Income to Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
N
NewGLab Pharma Co Ltd
KOSDAQ:214870
Income to Minority Interest
â‚©1B
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vidente Co Ltd
KOSDAQ:121800
Income to Minority Interest
â‚©140.2m
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A
T
Tovis Co Ltd
KOSDAQ:051360
Income to Minority Interest
-â‚©2.2B
CAGR 3-Years
N/A
CAGR 5-Years
-157%
CAGR 10-Years
N/A
F
Furonteer Co Ltd
KOSDAQ:370090
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Park Systems Corp
KOSDAQ:140860
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Woori Technology Inc
KOSDAQ:032820
Income to Minority Interest
â‚©900.7m
CAGR 3-Years
-14%
CAGR 5-Years
29%
CAGR 10-Years
-5%
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N

See Also

What is NewGLab Pharma Co Ltd's Income to Minority Interest?
Income to Minority Interest
1B KRW

Based on the financial report for Sep 30, 2024, NewGLab Pharma Co Ltd's Income to Minority Interest amounts to 1B KRW.

What is NewGLab Pharma Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 3Y
43%

Over the last year, the Income to Minority Interest growth was -59%. The average annual Income to Minority Interest growth rates for NewGLab Pharma Co Ltd have been 43% over the past three years .

Back to Top